Blind visual review
Three fresh, isolated GPT-6 Astra judges at high reasoning reviewed the same 45 opaque screenshots through craft, journey and trust lenses. Each saw all five gallery slides at readable main-image size at 390 and 1440 pixels. They received the locked rubric, neutral attachment index and output schema only—no conversation, prior results, user feedback, change summaries, source provenance, build notes, known concerns, score target, page history, separate report pages or product-reference attachments.
| Overall (weighted) | 8.20 |
|---|---|
| Visual craft | 8.63 |
| Brand distinctiveness | 8.20 |
| Journey | 7.93 |
| Trust/proof | 7.90 |
| Offer clarity | 8.33 |
| Mobile usability | 8.00 |
Independent findings
Against R21.26, the weighted score is effectively flat at 8.20 versus 8.22. Visual craft rises 0.03 to 8.63 and brand distinctiveness rises 0.03 to 8.20. Journey falls 0.07 to 7.93, trust/proof falls 0.10 to 7.90, offer clarity remains 8.33, and mobile usability falls 0.03 to 8.00. Across the fresh R21.28 verdicts, recurring concerns are the floating purchase strip overlapping visible reading content while omitting shipping and subscription context, repeated social proof before practical FAQs, and the 2,600 five-star claim lacking inspectable aggregate and source context. The trust lens additionally requests a clearer distinction between product-quality testing and support for efficacy and dose framing. These are independent screenshot-based visual judgments, not performance or conversion measurements.
Exact judge results
Craft lens — scores, evidence and exact blockers
Visual craft — 8.6
Strong photographic lighting, deliberate image crops, generous spacing, and restrained sans/italic-serif typography create a polished composition (evidence/asset-015.jpg, evidence/asset-017.jpg, evidence/asset-020.jpg). The main weaknesses are the floating CTA overlapping headings and testimonial captions, plus small, faint supporting text (evidence/asset-018.jpg, evidence/asset-019.jpg, evidence/asset-029.jpg). Motion and rendering quality beyond these captures remain unknown.
Brand distinctiveness — 8.2
Deep green, cream, lime accents, marble surfaces, and prismatic bottle photography form a coherent identity (evidence/asset-015.jpg, evidence/asset-024.jpg). Asymmetric image corners and serif emphasis add recognizable details (evidence/asset-020.jpg). Distinctiveness weakens in the repeated pale testimonial cards and conventional FAQ treatment (evidence/asset-021.jpg, evidence/asset-022.jpg, evidence/asset-023.jpg). Competitive uniqueness cannot be established from this evidence.
Journey — 8.0
The sequence moves clearly from proposition and purchase options through ingredients, label transparency, customer experiences, daily use, FAQs, and a closing purchase module (evidence/asset-015.jpg through evidence/asset-024.jpg). On mobile, the gallery separates the initial offer from the complete purchase selector, adding scrolling before commitment (evidence/asset-001.jpg, evidence/asset-029.jpg). Sticky prompts preserve access but interrupt reading in several captures. Checkout completion and navigation behavior are untested.
Trust/proof — 8.1
Preserve the readable label, named laboratory, batch identifier, dated report, original-PDF link, and explicit distinction between laboratory measurement and formulation records (evidence/asset-018.jpg, evidence/asset-034.jpg, evidence/asset-035.jpg). Testimonials include handles and original-source links (evidence/asset-028.jpg, evidence/asset-032.jpg). However, the prominent 2,600 five-star claim lacks a visible total review count, distribution, or aggregate source alongside the curated reviews (evidence/asset-010.jpg, evidence/asset-031.jpg). Underlying authenticity and report contents remain unverified.
Offer clarity — 8.5
Purchase states clearly distinguish the free introductory subscription bottle, $9.99 shipping, $50.99 every two months, and $59.99 one-time purchase; cancellation and guarantee language are nearby (evidence/asset-002.jpg, evidence/asset-003.jpg, evidence/asset-016.jpg). The persistent FREE strip omits shipping and renewal context, weakening clarity when viewed independently (evidence/asset-012.jpg, evidence/asset-024.jpg). Final checkout totals and recurring shipping treatment are not shown.
Mobile usability — 8.0
The 360px and 390px layouts retain readable headlines, comfortable side margins, broad purchase controls, and useful carousel previews (evidence/asset-025.jpg, evidence/asset-029.jpg, evidence/asset-028.jpg). The certificate modal adapts its search controls vertically (evidence/asset-033.jpg). Small secondary copy and the persistent bottom bar reduce reading comfort and visible content space (evidence/asset-006.jpg, evidence/asset-029.jpg). Touch behavior, keyboard handling, and assistive-technology support cannot be established from screenshots.
Exact blockers
- The floating purchase strip visibly covers section headings, testimonial captions, and FAQ content, interrupting otherwise careful compositions (evidence/asset-018.jpg, evidence/asset-019.jpg, evidence/asset-022.jpg). Highest-impact fix: place the persistent purchase control in a reserved viewport area so page content does not render underneath it.
- The mobile purchase hierarchy places the complete selector after the large product gallery, while the initial offer uses a small arrow to signal action (evidence/asset-001.jpg, evidence/asset-025.jpg, evidence/asset-029.jpg). Highest-impact fix: provide an explicit primary purchase button beside the initial offer that takes users directly to the selector, retaining shipping and renewal terms.
- The prominent 2,600 five-star review claim is supported visually by selected positive testimonials without aggregate review context (evidence/asset-010.jpg, evidence/asset-021.jpg, evidence/asset-031.jpg). Highest-impact fix: attach the claim to a sourced review summary showing total count, rating distribution, and access to the complete review collection.
Evidence limitations
- Visual craft and brand judgments use the supplied static captures; motion, loading transitions, and competitive distinctiveness were not established. Supplementary gallery views were not treated as independent page designs.
- Journey and offer evidence includes alternate purchase states but does not establish click behavior, selection persistence, checkout totals, or successful purchasing.
- Trust assessment concerns visible presentation. Original reports, review provenance, purchaser verification, and scientific support were not independently inspected.
- Mobile evidence covers the supplied 360px and 390px page captures and supplementary gallery views. Keyboard navigation, screen readers, modal focus, internal scrolling, and measured contrast were not tested.
- Measured performance is unknown. No conversion lift or other commercial outcome is inferred.
Journey lens — scores, evidence and exact blockers
Visual craft — 8.6
Strengths: cohesive forest-green and cream palette, expressive serif accents, strong product photography, and controlled desktop alignment (asset-015.jpg, asset-017.jpg, asset-020.jpg). Flaws: the square closing purchase panel breaks the rounded component language, while the floating CTA visually interrupts lower-page compositions (asset-024.jpg, asset-021.jpg). Limitation: screenshots cannot establish animation quality or rendering stability.
Brand distinctiveness — 8.2
Strengths: iridescent packaging, glass and stone imagery, and recurring typography create a recognizable visual identity (asset-015.jpg, asset-017.jpg, asset-024.jpg). Flaws: repeated simplicity and daily-routine messaging becomes less specific to this product across lifestyle and review sections (asset-020.jpg, asset-022.jpg, asset-031.jpg). Limitation: competitive distinctiveness cannot be established without comparison pages.
Journey — 7.8
Strengths: the page progresses coherently from product and offer to ingredients, label, customer experiences, routine, FAQs, and a closing purchase opportunity; formula and review links provide shortcuts (asset-015.jpg through asset-024.jpg). Flaws: video testimonials, routine content, a featured review, and further reviews extend the journey before subscription and expectation FAQs; mobile buyers traverse the large gallery before reaching the complete selector (asset-001.jpg, asset-029.jpg, asset-007.jpg through asset-012.jpg). Limitation: actual anchor destinations, checkout continuity, and accordion behavior are not demonstrated.
Trust/proof — 8.0
Strengths: readable supplement facts, manufacturing geography, named laboratory, batch/date metadata, original-PDF access, and an explicit distinction between assay results and formulation records make the evidence unusually concrete (asset-018.jpg, asset-034.jpg, asset-035.jpg). Customer handles and original-source links add traceability (asset-007.jpg, asset-032.jpg). Flaws: the prominent 2,600 five-star claim leads into curated positive reviews without a visible overall rating distribution or collection methodology (asset-021.jpg, asset-022.jpg, asset-031.jpg). Limitation: report contents, review authenticity, and scientific support behind closed disclosures remain unverified.
Offer clarity — 8.2
Strengths: subscription and one-time states clearly distinguish the free first bottle plus $9.99 shipping from $59.99 plus shipping; renewal frequency, $50.99 renewal price, cancellation flexibility, and returns appear beside purchase controls (asset-002.jpg, asset-003.jpg, asset-016.jpg, asset-024.jpg). Flaws: the persistent 'FREE first bottle' bar omits shipping and subscription context when those disclosures are offscreen (asset-008.jpg, asset-012.jpg, asset-021.jpg). Limitation: checkout totals and whether the sticky offer follows selection changes are unknown.
Mobile usability — 8.0
Strengths: readable heading reflow at 360px, broad purchase controls, clearly differentiated radio states, and a vertically adapted report dialog support small-screen use (asset-025.jpg, asset-029.jpg, asset-026.jpg). Flaws: the persistent bottom bar covers visible portions of label and review content at captured positions, and secondary pricing/report text is relatively small and muted (asset-006.jpg, asset-027.jpg, asset-029.jpg). Limitation: touch behavior, focus management, modal scrolling, accessibility measurements, and performance are not supplied.
Exact blockers
- The persistent acquisition CTA advertises 'FREE first bottle' without its shipping charge or subscription commitment while the full terms are offscreen (asset-008.jpg, asset-012.jpg, asset-021.jpg). Highest-impact fix: include '$9.99 shipping; subscription' in the bar and expose renewal terms directly beside its action.
- The journey repeats social proof across videos, a featured review, and additional review cards, with routine content between them, before addressing practical FAQs (asset-007.jpg through asset-012.jpg; asset-019.jpg through asset-023.jpg). Highest-impact fix: consolidate customer proof and move expectation, subscription, and suitability answers closer to the first purchase selector.
- The 2,600 five-star claim is supported visually by selected positive testimonials rather than an inspectable review summary (asset-021.jpg, asset-022.jpg, asset-031.jpg). Highest-impact fix: add the overall rating, total review count, rating distribution, collection source, and access to all ratings beside the claim.
Evidence limitations
- Static screenshots establish visible layouts and supplied states, not successful interactions or end-to-end purchase behavior.
- Measured performance is unknown; no loading, responsiveness, or layout-shift measurements were supplied.
- Original report contents, scientific disclosures, FAQ answers, external testimonial sources, and checkout were not shown.
- Keyboard navigation, screen-reader semantics, measured contrast, touch targets, and modal focus/scroll handling cannot be established from these images.
- Supplementary gallery and packaging views were used for content and consistency comparison, not scored as standalone page designs.
- No conversion lift, commercial outcomes, or review authenticity can be inferred from this evidence.
Trust lens — scores, evidence and exact blockers
Visual craft — 8.7
Strengths: controlled green and cream palette, strong typography, polished product photography and generous alignment create a coherent presentation (asset-015.jpg, asset-017.jpg, asset-020.jpg). Mobile headings retain clear hierarchy (asset-025.jpg). Flaws: the square closing purchase panel departs from the rounded primary panel, and the floating CTA overlaps editorial content (asset-024.jpg, asset-018.jpg). Limits: screenshots establish static craft, not animation quality or measured performance.
Brand distinctiveness — 8.2
Strengths: iridescent packaging, glass and dark stone photography, italic serif accents and capsule imagery form a recognizable visual vocabulary (asset-015.jpg, asset-017.jpg, asset-019.jpg). The gallery maintains that vocabulary across product, routine and educational views (asset-036.jpg through asset-045.jpg). Flaws: broad wellness phrases and conventional review cards provide less distinctiveness than the imagery (asset-020.jpg, asset-022.jpg). Limits: no competitive comparison or brand research is supplied.
Journey — 8.0
Strengths: the sequence moves coherently from product and purchase choice through ingredients, label, customer stories, routine, reviews and FAQs to a closing offer (asset-015.jpg through asset-024.jpg). Formula and batch-report links provide useful investigation paths beside purchase controls (asset-016.jpg, asset-029.jpg). Flaws: separate video, routine and written-review sections make the middle journey lengthy; the floating CTA interrupts reading at several positions (asset-019.jpg, asset-021.jpg, asset-022.jpg). Limits: navigation destinations, checkout completion and accordion behavior cannot be established from these states.
Trust/proof — 7.6
Strengths: the full label, manufacturing geography, named laboratory, batch identifier, report date and original-PDF link provide unusually concrete verification cues (asset-018.jpg, asset-026.jpg, asset-034.jpg). The expanded explanation explicitly distinguishes laboratory measurement from glycine recorded by formulation input, a valuable qualification to preserve (asset-035.jpg). Customer handles, original-video links, purchaser badges and return terms add accountability cues (asset-028.jpg, asset-031.jpg, asset-014.jpg). Flaws: the prominent 2,600 five-star claim lacks adjacent source, total-review denominator or rating distribution, while the visible reviews are selected positive examples (asset-010.jpg, asset-021.jpg, asset-031.jpg). Brain-fog framing and energy testimonials are more prominent than the visible explanation of what evidence supports those outcomes (asset-001.jpg, asset-032.jpg, asset-039.jpg). Limits: review authenticity, laboratory findings, linked research and unopened FAQ answers are unverified.
Offer clarity — 8.3
Strengths: subscription and one-time states visibly distinguish FREE plus $9.99 shipping, subsequent $50.99 charges every two months, and $59.99 plus shipping without recurring orders (asset-002.jpg, asset-003.jpg, asset-016.jpg). Cancellation flexibility and opened-bottle returns are stated near purchase controls (asset-024.jpg, asset-029.jpg). Flaws: the persistent FREE-first-bottle bar omits shipping and subscription qualifications when those terms have scrolled away; the one-time shipping amount remains unspecified (asset-012.jpg, asset-022.jpg, asset-002.jpg). Limits: checkout totals, subsequent shipping charges and actual cancellation procedures are not supplied.
Mobile usability — 8.0
Strengths: readable stacked layouts, large purchase buttons, clear selected offer states and a well-organized batch-report modal work visually at narrow widths (asset-025.jpg, asset-029.jpg, asset-033.jpg). Partial adjacent cards and explicit swipe guidance communicate the video carousel (asset-028.jpg). Flaws: the fixed bottom offer bar covers portions of label and review content in captured states, while secondary gallery and metadata text is small (asset-006.jpg, asset-027.jpg, asset-036.jpg). Limits: scrolling recovery, touch behavior, modal focus management, keyboard access and screen-reader semantics are untested.
Exact blockers
- Review evidence is less traceable than the prominence of the claim warrants: 2,600 five-star reviews leads into selected positive reviews without an adjacent source, total count or distribution (asset-010.jpg, asset-021.jpg, asset-031.jpg). Highest-impact fix: connect the headline count to an inspectable review collection with source, total reviews, rating distribution and a concise explanation of purchaser verification.
- The visible evidence does not clearly separate product-quality testing from support for the brain-fog and energy framing; the label also shows 6,250% Daily Value without nearby dose rationale (asset-001.jpg, asset-018.jpg, asset-032.jpg, asset-039.jpg). Highest-impact fix: add a concise, sourced explanation beside the benefit and dose claims that states their scope and limitations, and explicitly distinguishes the COA's quality findings from evidence about outcomes.
- The persistent FREE offer loses its shipping and subscription context and overlaps reading content across both layouts (asset-006.jpg, asset-012.jpg, asset-018.jpg, asset-022.jpg). Highest-impact fix: qualify the sticky offer with shipping and subscription terms, respect the selected purchase option, and adjust placement or visibility so it does not cover content.
Evidence limitations
- Only supplied screenshots were reviewed; measured performance and commercial outcomes are unknown.
- The original COA PDF, batch-search results, linked science, return policy details and checkout were not supplied. Their accuracy and functionality remain unverified.
- Review counts, purchaser verification and customer-video provenance cannot be independently authenticated from screenshots; no fabrication is inferred.
- Closed science, guarantee and FAQ accordions may contain additional qualifications. Their unseen contents were not treated as observed omissions.
- Static captures show overlap at specific scroll positions, but do not establish that covered content is permanently inaccessible.
- Accessibility semantics, contrast measurements, keyboard navigation, video playback and responsive behavior outside the supplied dimensions were not tested.
Evidence limits
The review is based on static screenshots. It does not measure loading speed, conversion, checkout behavior, link destinations, review authenticity, laboratory findings, benefit substantiation, accessibility, touch behavior, or interaction reliability. The visible floating bar overlaps content at captured positions; that does not prove the underlying content is permanently unreachable by scrolling.
Before the judge run, all 10 gallery states—five slides at 390 pixels and five at 1440 pixels—were captured after settling with a maximum measured offset delta of 0 pixels. Visible community-video posters were loaded before capture. Public/source identity checks passed, all 40 programmed captures completed with zero errors, and the 45-image opaque packet passed selector and coverage preflight. No page bytes changed during capture or review.